ERBB2 and breast cancer: In addition, we found that the PTK2 mRNA expression levels are significantly higher also in ER+/PR+/HER2- and ER-/PR-/HER2+ breast tumors respect to normal breast tissues, however the TNBC samples displayed the highest expression levels among the different breast cancer phenotypes (Fig. 1c).